Planta Med 2009; 75 - SL45
DOI: 10.1055/s-0029-1234300

Functional genomics of immuno-modulatory activities of medicinal plant extracts/phytocompounds in human dendritic cells/monocytes

NS Yang 1, CY Wang 1, SC Chiu 1, LF Shyur 1
  • 1Agricultural Biotechnology Research Center, Academia Sinica, No.128, Sec. 2, Academia Rd., Nangang District, 115 Taipei, Taiwan

Echinacea spp. extracts and the derived phytocompounds have been used as botanical drugs or nutraceuticals for immuno-modulatory functions [1]. Dendritic cells (DCs) play an important role in both innate and adaptive immunities. Recently, we investigated differential gene expression profiles in human immature DCs (iDCs) in response to treatment with a butanol fraction extracted from Echinacea purpurea, denoted [BF/S+L/Ep]. DNA microarray results showed significant up regulation of specific genes for cytokines (IL-8, IL-1β, and IL-18) and chemokines (CXCL 2, CCL 5, and CCL 2) within 4h after treatment. Bioinformatics analysis revealed a key-signaling network involving immune-modulatory molecules leading to the activation of a downstream adenylate cyclase 8. Proteomic analysis showed increased expression of antioxidant and cytoskeletal proteins after this treatment [1,2]. Human monocytes (THP-1) were also tested under LPS stimulation with [BF/S+L/Ep], along with three anti-inflammatory phytocompounds (emodium, shikonin and cytopiloyne). Initially (within 0.5h), shikonin [3] and emodin significantly inhibited the expression of approximately 50 genes, most notably cytokines TNF-α, IL-1 and IL-4, chemokines CCL4 and CCL8, and inflammatory modulators NFATC3 and PTGS2. Cytopiloyne and BF/S+L/Ep did not inhibit early expression of these 50 genes, but inhibited the late-stage expression (˜12 hours) for many of them, particularly IL-4, NFATC3 and PTGS2, and the cell migration and chemokine molecules CDH1 and ITGA2. The ERK 1/2 activation pathway was identified as the putative target of BF/S+L/Ep and cytopiloyne. These studies provide useful information for future development of phytocompounds/extracts as defined health supplements or herbal medicines.

Acknowledgements: Agriculture Biotechnology Research Center, Academia Sinica, Taipei, Taiwan. National Science Council , Taiwan.

References: [1] Wang, C.Y. et al. (2008) BMC Genomics. 9:479.

[2] Wang, C.Y. et al. (2006) Genomics 88:801-808.

[3] Staniforth, V. et al. (2004) J. Biol. Chem. 279:5877–5885.